The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
US-listed companies Indivior and Fortive have announced significant capital return initiatives through new share repurchase programs. Indivior entered into an accelerated share repurchase agreement with Barclays Bank PLC, valued at $175 million. Simultaneously, Fortive's Board of Directors approved an expansion of its buyback program, bringing the total authorized amount to 20 million shares. These strategic moves signal strong corporate confidence in long-term valuations and robust cash flow management. Such buybacks typically provide downward price protection and enhance earnings per share (EPS) metrics by reducing total share supply. The announcements highlight a continuing trend of proactive capital allocation within the pharmaceutical and technology sectors to drive shareholder value.
Sign in to access this content
Sign In